"7" "!"!
D."?!"
>(
3 >
3
G
>(
' >(
3
* 3 G
- /
3
"
"
' - 8,/
3 ?
- ?!/ 3
>( ' >( "
1302. Development of B Lineage Specific Lentiviral Vectors for Use in Gene Therapy of Human B Lymphocyte Disorders Maria I. Garcia-Lloret,1 Keun Chae,1 Ruby Tabuchi,1 Carolyn Lutzko,2 Don Khon,2 David J. Rawlings.1 1 Department of Pediatrics, UCLA, Los Angeles, California, United States; 2Children′s Hospital, Los Angeles, California, United States. 4 " -(*/
3 0
2 -C(/ 2 ' (* ?!
'
7 ?! 3 I 3 2 " -C2"D /
C(I 3 C(
2 #. !A 3
-TB
/ 3 ->/
?! 3 ="& $;5 - I 2,5/
3
2 3 '
>2,5
?! 3 2
3
#
- #)/
1 &"89 ?! 2 *2,5 3
2 - 2O 2O 2M 2/ C2"D
2 >2,5 -
>!A >#./ ?! 3 -,9"&9H 89",&H/ 3 -#? :99"8=99 =99"B99/ C "
3 2 #J 2
8,
C2"D ($% *)$ C(
* 3
?! 3
$ 85J -2 / >2,5
?! 1
$85J $==J- /
>!A >#. >2,5
3 2 2
S426
1303. Optimization of HIV -1 Based Lentiviral V ectors HIV-1 Vectors for Gene-Modification of Leukemia Cells Aaron C. Logan,1, 2 Donald B. Kohn.1, 2 1 Division of Research Immunology/Bone Marrow Transplantation, Childrens Hospital Los Angeles, Los Angeles, CA, United States; 2 Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States. D " # 3 " E
) 3 0
C."8
##D.
G
" 3 -!! / C."8
" 3 !! " 3 !!
#) !! J !! " ?! G
8,
3
!! J " 3 8,",6 !! " 2 !!
" 3 1 3
#. 4= #!(.
3 6"8, 2 =",& ,"= ( !! &V 3 -6"8:H / '
(.69 D @
3 -≤&9H / ' 3 0!@>
3 2
!! (.69
3
1304. T ectors Transcriptional Targeting Vectors ranscriptional T argeting of Lentiviral V TR Enhancer Replacement LTR by L Francesco Lotti,1 Emilio Menguzzato,1 Luigi Naldini,2 Fulvio Mavilio,1 Giuliana Ferrari.1 1 San Raffaele-Telethon Institute for Gene Therapy (HSR-TIGET), Istituto Scientifico H.S.Raffaele, Milano, Italy; 2Institute for Cancer Research and Treatment, University of Torino Medical School, Torino, Italy. 1 " -C(/ 3 C."
" " 0
D @ "
Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
"7" "!"! ' -C(,/
" ' '"8
" 4= D @
C."8
D @
3 -?!/ -$D*?@/
3
.(."
$=6J %
C( 3 G
" - / *)$%($ - /
C. D @
3 " >3
D @
%
" -0!@>/
@*' " '
E 3
3
1305. Addition of the B-Interferon SAR Leads to an Orientation Dependent Increase in T ransgene Transgene Expression in Stem Cells and Their Progeny Carolyn Lutzko,1 Stephanie Halene, Dinthi Senadheera,1 Denise Carbonaro, Donald B. Kohn. 1 Research Immunology/Bone Marrow Transplantation, Childrens Hospital Los Angeles, Los Angeles, CA, United States. 3 C 3 #D.
0
#*$
3
3
2" -('@/ 3 3 3
#D. #*$ J%" ('@ -?/ -@/
3 *C = = ?5
( 3 ?5 *C= =
?' G
?!
3 86 G H ?!J ?5%H ?!J *C= =
' 3 ?5
#D. 99=
('@"?
=" 98( ('@"@
998 #*$ 3 ?5 '
#*$ 9;9: 99, #*$('@"? ('@" @ ('@"? 3 # (
3
('@"@ ('@"?
0 3
#*$ ('@"? 3 ?! +?! ('@"? ) 1
#*$" ?!#*$" +?!#*$" ?!"('@"? #*$" +?!"('@"?' ,389B
7 / #*$" ?! #*$" +?!"('@ /#*$" +?! #*$" ?!"('@?
' :"
"
89",&H Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
3
3 ?! +?!
('@"? ," #?
('@ ?
3
('@"?
3 ' 3
('@ $
3 " (
3 ('@ L, " ('@
3
('@"@
3
) 3 ('@ 3
1306. Using a Random-Display Envelope Library T o To Target a Retroviral V ector to a Human Osteosarcoma Vector Cell Line Keith Bupp, Monica J. Roth. 1 Biochemistry, Robert Wood Johnson Medical School/UMDNJ, Piscataway, NJ, United States. "
86=2 ->/ " >
' -? D."'/ B8> > > 3
3
? >
86=2 0
> -D8/
86=2 -8B ± 88>J6 / ,5= -85 ± 9;:>J& / 86=2 ? D."' -6 ± ,>J8 / ,5= 3 (.69 >8 (3 'C5,;
D8 - 899 /
D8 ,5=! 3 9,;H ,5= -&8 ± ,5>J, / D8 ,5=
>
D8 ? D."' ? D." D8>
"
D8
"
> >
1307. Fetal Gene Therapy - Lentiviral V ectors in the Vectors Sheep - A Pilot Study Jane Fleming,1 Samantha Ginn,1 Christine Smyth,1 Julie Curtin,1 Meredith Ward,1 Ian E. Alexander,1 Eugenie Lumbers.2 1 Gene Therapy Research Unit, The Children′s Hospital at Westmead and Children′s Medical Research Institute, Westmead, NSW, Australia; 2School of Physiology and Pharmacology, University of New South Wales, Sydney, NSW, Australia. E
S427